and 'cerebrovascular disease', with or without hypertension. The death certification system unfortunately does not help in assessing the frequency of dementia in those groups. Clinical, or rarely post-mortem, studies assume that dementia with cerebrovascular disease, brain infarcts or hypertension is relatively rare, accounting for between 10% and 20% of dements.
The Mortality Statistics do show many people dying of hypertension seldom with any record of cerebrovascular involvement, and many more of cerebrovascular disease. Hypertension is associated, when haemorrhage and thrombosis are excluded, with cerebrovascular disease in a total of some 4000 cases: (436.0) 'acute but iII defined cerebrovascular disease', 1565 men and 1950 women; (437.0) 'generalised ischaemic cerebrovascular disease', I I7 men and 159 women; and (438.0) 'other and iII defined cerebrovascular disease', 101 men and 138 women.
The above groups, without mention of hypertension, include over 25000 people. The figures quoted are for 1978: there has been a steady rise in the number of cases in these categories over the years. If a proportion of such cases were demented this would somewhat alter the ideas about the incidence of various sorts of dementia. IVAN JANOTA 18 November 1980 Hypokalaemic thyrotoxic periodic paralysis From Professor Robert Volpe Department of Medicine University of Toronto, Ontario. Canada Dear Sir, In his letter on this topic (October 1980 Journal. p 757); Dr C P Petch remarked that 'No one has ever been able to explain ... why this complication of a common disease, so frequent in Japan, is so rare in Western Europe'.
. Surely the matter is one of genetics. Chinese patients with thyrotoxic periodic paralysis are found to have HLA antigens A2-Bw33 and Aw19-B17, and these are not present in patients without thyrotoxic periodic paralysis. On the other hand, in Chinese patients with Graves' disease the common HLA antigen is HLA-Bw46 or Bw46jB40. Thus, it would appear that when particular patients have both sets of antigens, the development of hyperthyroidism would also permit the trait of periodic paralysis to become manifest, whereas it would not become manifest if the hyperthyroidism did not occur. Thus the appearance of thyrotoxic periodic paralysis results from the presence of two coincidental genetic abnormalities which happen to be much more common in the genetic pool of Orientals than in Caucasians (Yeo P P B et al. 1978, British Medical Journal ii, 93(}-932 Medicine' would certainly not cause me to buy it; yet this book is first class and does much to remove the stigma of 'fringe', which the reviewer is at pains to remind us is so often the fate of hypnosis.
Then, again, we read that the chapter on the 'use of hypnosis in the psychiatric field ... might stimulate some psychiatrists to master hypnotic techniques'. When will some hypnotists realize that hypnosis is a therapy, not a technique? Perhaps they feel naked and powerless without their 'techniques'.
Possibly many psychiatrists have mastered the technique and long since gone to 'fresh fields and pastures new'. After all, Freud did . Yours sincerely GORDON AMBROSE 
